股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码：603359 证券简称：东珠生态 公告编号：2025-025 东珠生态环保股份有限公司 （一）生产经营情况 经公司自查，公司目前生产经营情况正常，市场环境、行业政策未发生重大 调整，内部生产经营秩序正常，除已披露信息外，不存在其他应披露而未披露的 重大事项。 重要内容提示： ●东珠生态环保股份有限公司（以下简称"公司"）股票价格于 2025 年 5 月 14日、5月15 日、5月16日连续三个交易日内收盘价格涨幅偏离值累计超过20%， 根据《上海证券交易所交易规则》的有关规定，属于交易异常波动情形。 ●经公司自查，并函询公司实际控制人及其一致行动人，截至本公告披露日， 公司不存在应披露而未披露的重大事项和风险事项。 ●经营业绩风险提示：公司于 2025 年 4 月 29 日披露了《2024 年年度报告》， 2024 年度，公司经营业绩出现较大幅度下滑，实现营业收入 37,593.16 万元，同 比下降 54.64%；实现归属于母公司所有者的净 ...

东珠生态：公司仅参股迪洛斯10%股权 智通财经5月16日电，东珠生态(603359.SH)发布异动公告，公司关注到近期市场存在关于参股子公司迪 洛斯人工智能科技（四川）有限公司的相关报道。公司仅参股迪洛斯10%股权，公司对迪洛斯不构成控 股关系，且公司与其暂无实质业务合作。此外，迪洛斯成立于2025年1月，目前尚处于初创阶段，其未 来经营业绩尚存在不确定性。 ...

Core Points - The company held its 2024 Annual General Meeting on May 19, 2025, chaired by Chairman Xi Huiming [1] - Various proposals were presented for shareholder approval, including the annual report, board and supervisory committee reports, financial settlement report, profit distribution plan, and financing plan for 2025 [2][3][4][6][9] Proposal Summaries - **Proposal 1: Annual Report** The company prepared the 2024 Annual Report and its summary, which has been approved by the audit committee, board, and supervisory committee [2][3] - **Proposal 2: Board Work Report** The board presented the 2024 Board Work Report, which includes independent directors' reports [3] - **Proposal 3: Supervisory Committee Work Report** The supervisory committee's work report for 2024 was presented for approval [4] - **Proposal 4: Financial Settlement Report** The company prepared the 2024 Financial Settlement Report, which has been approved by relevant committees [6] - **Proposal 5: Profit Distribution Plan** The company reported a net loss of 630.12 million yuan for 2024, leading to a proposal not to distribute profits for the year. The retained earnings will be used for operational needs and debt repayment [7][8] - **Proposal 6: Financing Plan for 2025** The company plans to apply for a credit limit of up to 4 billion yuan and a working capital loan of up to 1.5 billion yuan for 2025 [9] - **Proposal 7: Confirmation of Related Transactions** The company confirmed related transactions for 2024, ensuring they were necessary and conducted at fair market prices [10] - **Proposal 8: Expected Related Transactions for 2025** The company outlined expected related transactions for 2025, emphasizing fair pricing and normal business operations [19][20] - **Proposal 9: Audit Committee Report** The Audit Committee's performance report for 2024 was presented for approval [22] - **Proposal 10: Director and Supervisor Remuneration** The proposed remuneration for directors and supervisors for 2025 was detailed, with specific amounts for each position [24] - **Proposal 11: Authorization for Stock Issuance** The company seeks authorization to issue up to 300 million yuan in stock to specific investors, with conditions outlined for the issuance process [26][27][28]

东珠生态环保股份有限公司 2024 年年度股东大会会议资料 江苏•无锡 二〇二五年五月 | 2024 | 年年度股东大会议程 | | 1 | | | --- | --- | --- | --- | --- | | 议案一 | | | | 2 | | | 关于《公司 年年度报告》及其摘要的议案 | 2024 | | 2 | | 议案二 | | | | 3 | | | 关于《公司 年度董事会工作报告》的议案 | 2024 | | 3 | | 议案三 | | | | 4 | | | 关于《公司 年度监事会工作报告》的议案 | 2024 | | 4 | | 议案四 | | | | 5 | | | 关于《公司 年度财务决算报告》的议案 | 2024 | | 5 | | 议案五 | | | | 6 | | | 关于《公司 年度利润分配预案》的议案 | 2024 | | 6 | | 议案六 | | | | 8 | | | 关于《公司 年度融资额度计划》的议案 | 2025 | | 8 | | 议案七 | | | | 9 | | | 关于《对公司 年度关联交易予以确认》的议案 | 2024 | | 9 | | 议案八 | | ...

证券代码：603359 证券简称：东珠生态 公告编号：2025-024 重要内容提示： ●东珠生态环保股份有限公司（以下简称"公司"）股票价格于 2025 年 5 月 6 日、5 月 7 日、5 月 8 日连续三个交易日内收盘价格跌幅偏离值累计超过 20%， 根据《上海证券交易所交易规则》的有关规定，属于交易异常波动情形。 ●经公司自查，并函询公司实际控制人及其一致行动人，截至本公告披露日， 公司不存在应披露而未披露的重大事项和风险事项。 ●经营业绩风险提示：公司于 2025 年 4 月 29 日披露了《2024 年年度报告》， 2024 年度，公司经营业绩出现较大幅度下滑，实现营业收入 37,593.16 万元，同 比下降 54.64%；实现归属于母公司所有者的净利润-63,012.34 万元。 ●相关媒体报道、市场传闻说明及风险提示：公司关注到近期市场存在关于 参股子公司迪洛斯人工智能科技（四川）有限公司（以下简称"迪洛斯"）的相关 报道。公司仅参股迪洛斯 10%股权，公司对迪洛斯不构成控股关系，且公司与其 暂无实质业务合作。此外，迪洛斯成立于 2025 年 1 月，目前尚处于初创阶段， 其未来经营业绩尚 ...

Group 1 - National Integrated Circuit Industry Fund plans to reduce its stake in Jiangbolong by no more than 4,159,815 shares, accounting for 1.00% of the total share capital, between May 27, 2025, and August 26, 2025 [1] - The reduction is due to the fund's operational management needs and will be executed through centralized bidding at market prices [1] - The implementation of this reduction plan will not lead to a change in the company's control or significantly impact its governance structure and ongoing operations [1] Group 2 - Haitai Weiye has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue no more than 710.52 million overseas listed ordinary shares [2] - The listing will take place on the main board of the Hong Kong Stock Exchange, but the matter still carries uncertainties [2] Group 3 - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection starting May 1, 2025, which is expected to negatively impact sales revenue [3] - The drug generated approximately RMB 210 million in sales for the year 2024, representing 29% of the company's total sales revenue [3] - The price adjustment may lead to a risk of single product loss for the drug in 2025 [3] Group 4 - Xinyuan Technology's director expressed inability to guarantee the authenticity and completeness of the 2024 annual report and related financial documents, citing significant issues identified by the audit firm [4] - The company has received a notice of investigation from the securities regulatory authority, and the audit report issued was unable to express an opinion [4] Group 5 - ST Xinchao announced that its stock will be suspended from trading starting May 6, 2025, due to the inability to disclose the audited 2024 annual report and the 2025 Q1 report within the legal timeframe [5] - If the company fails to disclose the 2024 annual report within two months of the suspension, it will face delisting risk warnings [5] Group 6 - Huakang Clean has pre-won a project worth RMB 167 million [6] - Tongguang Cable has pre-won a procurement project from the State Grid valued at RMB 142 million [6] - Fengmao Co. has increased its investment in a production base in Thailand to RMB 26 million [6] Group 7 - Huaren Pharmaceutical's wholly-owned subsidiary has obtained a medical device registration certificate for wound dressings [7] Group 8 - Major shareholders of Kairun Co. plan to reduce their holdings by no more than 9 million shares [10] - CITIC Securities has completed its reduction plan for China Gold [10] - The reduction plan for Hengfeng Information's director and vice president has been completed [10]

Core Viewpoint - Several listed companies in the Shanghai and Shenzhen markets have announced significant updates, including stock suspensions, name changes, and financial adjustments, which may present both opportunities and risks for investors [4][5][8][10]. Group 1: Stock Suspension and Changes - ST Xinchao will suspend its stock from May 6, 2025, due to the inability to disclose audited financial reports within the legal timeframe, with a risk of delisting if reports are not provided within two months [4]. - Wolong Real Estate plans to change its stock name to "Wolong New Energy" to align with national carbon neutrality policies and explore new profit growth areas [5]. Group 2: Financial and Operational Updates - Dongzhu Ecology clarified that it holds only a 10% stake in Dilos AI Technology and has no substantial business cooperation with it, indicating potential uncertainties in future performance [6][7]. - Haitian Flavor Industry has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue up to 710.52 million shares for overseas listing, though uncertainties remain [8]. - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection, which generated approximately RMB 210 million in sales in 2024, accounting for 29% of total revenue, potentially leading to losses in 2025 [10]. Group 3: Shareholding and Financing Activities - Jiangbolong's major shareholder, the National Integrated Circuit Industry Investment Fund, plans to reduce its stake by up to 1% through market transactions between May 27 and August 26, 2025, without affecting control [12][13]. - Cambrian Technology intends to raise no more than RMB 4.98 billion through a private placement to fund projects related to large model chip and software platforms and to supplement working capital [14]. - Jinzhen Co. plans to sell up to 5 million shares from its repurchased stock, which amounts to 50% of the total repurchased shares, to maintain company value and shareholder interests [15]. Group 4: Major Contracts and Procurement Wins - Aolaide's subsidiary signed a sales contract worth RMB 655 million with Chengdu BOE Display Technology, expected to positively impact the company's performance in 2025 and 2026 [16]. - Tongguang Cable is a candidate for two procurement projects from the State Grid Corporation, with a total expected bid amount of RMB 142 million, representing approximately 5.49% of the company's total revenue for 2024 [17].

Group 1 - ST Xinchao is unable to disclose its audited annual report for 2024 and Q1 2025 by the legal deadline, leading to a stock suspension starting May 6, 2025. If the report is not disclosed within two months, the stock will face delisting risk warning [3] - Wolong Real Estate plans to change its stock name to "Wolong New Energy" to align with national "dual carbon" policies and to explore new profit growth points in the renewable energy sector [4] - Dongzhu Ecology clarifies that it only holds a 10% stake in Dilos AI Technology and has no substantial business cooperation with it, as Dilos is still in its early stages of development [5] Group 2 - Haitian Flavor Industry has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue up to 710.52 million shares for listing on the Hong Kong Stock Exchange, though uncertainties remain [6] - Jiawei New Energy's controlling shareholder received a warning letter from the Shenzhen Securities Regulatory Bureau for failing to fulfill a commitment to increase shareholding by at least 60 million yuan [7] - Fudan Zhangjiang will reduce the market retail price of its Doxorubicin Liposome Injection by no less than 35% starting May 1, 2025, which may negatively impact its sales revenue and lead to potential losses for this product in 2025 [8] Group 3 - Tongguang Cable is a pre-selected candidate for two procurement projects from the State Grid Corporation, with a total expected bid amount of 142 million yuan, representing approximately 5.49% of the company's total revenue for 2024 [12]

证券代码：603359 证券简称：东珠生态 公告编号：2025-023 公司股票于 4 月 28 日、4 月 29 日、4 月 30 日连续三个交易日内收盘价格涨 幅偏离值累计超过 20%，属于《上海证券交易所交易规则》规定的股票交易异常 波动情形。 东珠生态环保股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ●东珠生态环保股份有限公司（以下简称"公司"）股票价格于 2025 年 4 月 28日、4月29 日、4月30日连续三个交易日内收盘价格涨幅偏离值累计超过20%， 根据《上海证券交易所交易规则》的有关规定，属于交易异常波动情形。 ●经公司自查，并函询公司实际控制人及其一致行动人，截至本公告披露日， 公司不存在应披露而未披露的重大事项和风险事项。 ●经营业绩风险提示：公司于 2025 年 4 月 29 日披露了《2024 年年度报告》， 2024 年度，公司经营业绩出现较大幅度下滑，实现营业收入 37,593.16 万元，同 比下降 54.64%；实现归属于母公司所 ...

关于《东珠生态环保股份有限公司关于股票交易异 常波动的问询函》的回函 东珠生态环保股份有限公司董事会: 我们已收到《东珠生态环保股份有限公司关于股票交易异常波动 的问询函》,经认真自查核实,现就有关情况回复如下: 截止目前,我们作为东珠生态环保股份有限公司(以下简称"上 市公司"）的实际控制人,不存在对上市公司股票交易价格产生重大 影响的应披露而未披露的重大事项,包括但不限于重大资产重组、发 行股票、重大交易类事项、业务重组、股份回购、股权激励、破产重 整、重大业务合作、引进战略投资者等重大事项。 截止目前,我们作为东珠生态环保股份有限公司(以下简称"上 市公司")的实际控制人的一致行动人,不存在对上市公司股票交易 价格产生重大影响的应披露而未披露的重大事项,包括但不限于重大 资产重组、发行股票、重大交易类事项、业务重组、股份回购、股权 激励、破产重整、重大业务合作、引进战略投资者等重大事项。 不存在异常波动期间交易公司股票的情形。 特此回复。 2 - 7 - 2015年 4月30日 关于《东珠生态环保股份有限公司关于股票交易异 常波动的问询函》的回函 东珠生态环保股份有限公司董事会: 我们已收到《东珠生态环 ...